GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ABI-PP
Compound class:
Synthetic organic
Comment: D13-9001 is a pyridopyrimidine derivative that acts as a bacterial efflux pump inhibitor (EPI) [2]. EPIs have potential clinical utility as adjunctive therapeutic agents for the treatment of infections caused by Gram-negative pathogens.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Nakashima R, Sakurai K, Yamasaki S, Hayashi K, Nagata C, Hoshino K, Onodera Y, Nishino K, Yamaguchi A. (2013)
Structural basis for the inhibition of bacterial multidrug exporters. Nature, 500 (7460): 102-6. [PMID:23812586] |
|
2. Yoshida K, Nakayama K, Ohtsuka M, Kuru N, Yokomizo Y, Sakamoto A, Takemura M, Hoshino K, Kanda H, Nitanai H et al.. (2007)
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate. Bioorg Med Chem, 15 (22): 7087-97. [PMID:17869116] |
|
3. Zuo Z, Weng J, Wang W. (2016)
Insights into the Inhibitory Mechanism of D13-9001 to the Multidrug Transporter AcrB through Molecular Dynamics Simulations. J Phys Chem B, 120 (9): 2145-54. [PMID:26900716] |